ALLOCYTE
Live / Registered — Registered (as of 14 Mar 2023)
What this means for you
Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90836264
- Registration number
- 7001736
- Mark type
- Stylized text
- Filed
- 19 Jul 2021
- Published for opposition
- 15 Nov 2022
- Registered
- 14 Mar 2023
- Attorney of record
- Cheryl P. Leb
Goods and services
- Class 005 — Pharmaceuticals: Allograft based biologics products, namely, an advanced cellular bone matrix for promoting bone formation, excluding wound healing and/or stem cell products
Owner
- SANARA MEDTECH, INC., FORT WORTH, TX, US
- SCENDIA BIOLOGICS, LLC, Orlando, FL, US
- SCENDIA BIOLOGICS, LLC, Orlando, FL, US
- SCENDIA BIOLOGICS, LLC, Orlando, FL, US
Prosecution history
- 28 Feb 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jan 2023 — USE AMENDMENT FILED
- 08 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 10 Jan 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Nov 2022 — PUBLISHED FOR OPPOSITION
- 26 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED